(INTC) Intel Corporation Company Overview

US | Technology | Semiconductors | NASDAQ

(INTC) Intel Corporation Bundle

Get Full Bundle:
$9 $5
$9 $5
$9 $5
$19 $9
$9 $5
$9 $5
$9 $5
$9 $5
$9 $5

TOTAL:

What does Intel Corporation do?

Intel Corporation is a semiconductor designer, manufacturer, and platform company whose common stock trades under the symbol INTC on the Nasdaq Global Select Market. The company’s economic role is broader than selling PC processors: it designs x86-based client and server chips, provides related accelerators and networking components, operates a large internal manufacturing network, and is trying to turn that manufacturing base into a more credible external foundry business. Intel’s latest 2025 Form 10-K frames the company as strategically important because it combines leading-edge logic R&D and high-volume manufacturing in the United States.

INTC
Ticker; common stock listed on Nasdaq Global Select Market
3
Reportable segments: CCG, DCAI, and Intel Foundry
$52.9B
FY2025 net revenue, fiscal year ended Dec. 27, 2025
70%
FY2025 revenue from outside the United States, based on billing location

How Intel describes its identity

Intel’s own corporate purpose is to “create world-changing technology that improves the life of every person on the planet,” but the investor-relevant version is more specific: Intel is attempting to remain a central provider of compute silicon while rebuilding execution in manufacturing, product cadence, and customer trust. Its company overview emphasizes AI from the data center to the client and edge, while its financial filings define the measurable business: product revenue, foundry activity, manufacturing costs, R&D intensity, and capital structure.

Client CPUsData-center CPUsAI acceleratorsCustom ASICsAdvanced packagingExternal foundry services

Which markets does Intel serve?

The Client Computing Group sells platforms and processors for notebooks, desktops, workstations, AI PCs, and edge devices through OEMs and distributors. Data Center and AI sells CPUs, accelerators, NICs, IPUs, and custom silicon to cloud service providers, hyperscalers, OEMs, enterprises, telecom operators, and government customers. Intel Foundry develops process technologies and provides manufacturing, assembly, test, packaging, and design enablement. This makes Intel both a product company and an asset-heavy manufacturing company, a combination that creates strategic optionality but also high fixed costs.

Business area Main customers What the customer buys Why it matters
Client Computing Group PC OEMs, distributors, commercial buyers Client processors and platforms for PCs, workstations, gaming, and edge devices CCG is the largest disclosed product revenue base and still funds much of Intel’s reinvestment capacity.
Data Center and AI Hyperscalers, cloud providers, OEMs, telecom and enterprise customers Xeon CPUs, accelerators, networking, IPUs, and custom ASICs DCAI is where Intel must defend x86 relevance as AI shifts budgets toward GPU-heavy infrastructure.
Intel Foundry Internal Intel Products and targeted external chip customers Wafers, advanced packaging, assembly, test, design enablement, and process technology Foundry is the strategic swing factor: it could support supply-chain diversification, but it is loss-making today.

How does Intel make money, and which segment matters most?

Intel makes money by selling semiconductor products and platforms, not by charging subscription fees or advertising commissions. The revenue engine is product shipment volume multiplied by average selling price, adjusted by mix, customer incentives, product availability, and competitive pricing. Gross margin then depends on utilization, node cost, manufacturing yields, depreciation, product mix, and whether a product is manufactured internally or by third-party foundries. In practical terms, Intel Products currently earns the operating profit while Intel Foundry absorbs the heavy manufacturing cost base.

Products versus foundry economics

In FY2025, CCG generated $32.2B of segment revenue and $9.3B of operating income; DCAI generated $16.9B of segment revenue and $3.4B of operating income. Intel Foundry reported $17.8B of segment revenue but a $10.3B operating loss because foundry revenue includes internal manufacturing activity and the segment carries large technology development, manufacturing, depreciation, and capacity costs. Intel explains the operating design on its Intel Foundry overview: the ambition is a systems foundry with process nodes, packaging, test, IP, software, and ecosystem support.

Q1 2026 operating-segment revenue ranking
CCG$7.7B
Intel Foundry$5.4B
DCAI$5.1B
All other$0.6B
Segment revenue before consolidation effects; Q1 2026 total net revenue was $13.6B after $5.3B of intersegment eliminations.

Revenue streams and customer logic

A useful business-model map starts with four drivers: PC refresh demand in CCG, server and networking demand in DCAI, internal and future external wafer demand in Foundry, and product availability from Intel’s factory network. Intel’s strategy discussion points to AI, x86 revitalization, external foundry growth, and purpose-built ASICs and GPUs as priorities, but the current income statement still shows that Intel’s near-term profitability depends heavily on client and server products.

Design
Intel builds product roadmaps around x86 CPUs, AI PCs, Xeon platforms, accelerators, and custom silicon.
Manufacture
Internal fabs and packaging assets supply most Intel Products, with selected external manufacturing where needed.
Sell
OEMs, cloud customers, distributors, and hyperscalers buy platforms, components, and foundry services.
Convert
Profitability depends on yields, utilization, ASP, mix, R&D discipline, and how fast Foundry losses narrow.

What does Intel’s latest quarter show?

The latest official reporting package available before the next earnings cycle is Q1 2026, the quarter ended March 28, 2026. Intel’s Q1 2026 earnings release reported revenue of $13.6B, up 7% year over year, but GAAP net loss attributable to Intel was $3.7B, or $(0.73) per diluted share. That contrast is the heart of the current story: demand and revenue improved, while restructuring, foundry losses, and financing or mark-to-market items kept GAAP earnings negative.

$13.6B
Q1 2026 revenue, up 7% YoY
39.4%
Q1 2026 GAAP gross margin
$(3.1B)
Q1 2026 GAAP operating loss
$1.1B
Q1 2026 cash from operations

Revenue and margin signals

Intel’s Q1 2026 revenue exceeded Q1 2025 by $910M. Gross profit rose to $5.3B and gross margin improved to 39.4% from 36.9%, helped by lower cost of sales as a share of revenue. Operating loss widened to $3.1B because restructuring and other charges reached $4.1B, equal to 30.0% of revenue. Non-GAAP EPS was $0.29, but a research brief should not ignore the GAAP loss because it reflects the cost of reshaping the company.

Metric Q1 2026 Q1 2025 Interpretation
Net revenue $13.577B $12.667B Revenue improved, led by Intel Products and a 22% DCAI increase.
Gross profit $5.347B $4.672B Gross margin improved by 2.5 percentage points to 39.4%.
R&D $3.375B $3.640B R&D was still large, but lower as Intel reduced expenses.
Operating income (loss) $(3.136B) $(0.301B) Restructuring charges dominated the GAAP operating result.
Diluted EPS attributable to Intel $(0.73) $(0.19) GAAP EPS remained negative despite better revenue.
39.4%
GAAP gross margin in Q1 2026. The margin improved from 36.9% in Q1 2025, but operating margin was still negative because restructuring and foundry-related costs outweighed product gross profit.

Segment momentum in Q1 2026

Segment data from the Q1 2026 Form 10-Q shows why the headline revenue number needs decomposition. CCG revenue was $7.7B, up 1%; DCAI revenue was $5.1B, up 22%; Intel Foundry revenue was $5.4B, up 16%; and All Other revenue was $0.6B, down 33% because Altera was deconsolidated after the 2025 divestiture. The strong product operating income from CCG and DCAI was partly offset by a $2.4B Foundry operating loss and $5.1B of corporate unallocated expenses.

How strong are Intel’s profitability, cash flow, and balance sheet?

Intel’s financial strength is mixed. The company still has large revenue, product operating income, significant cash and investments, and a strategic role in U.S. manufacturing. It also has high debt, large capex requirements, negative GAAP operating income, and a foundry business that is not yet self-funding. A student or investor should therefore separate “product franchise strength” from “manufacturing turnaround burden.”

Annual baseline: FY2025 versus FY2024

For FY2025, Intel reported $52.9B of net revenue, down only $0.2B from FY2024, but the composition improved: gross margin rose to 34.8% from 32.7%, operating margin improved to a 4.2% loss from a 22.0% loss, and net loss attributable to Intel narrowed to $0.3B from $18.8B. That is progress, but not full recovery. CCG and DCAI together generated $12.7B of FY2025 operating income, while Foundry lost $10.3B and corporate unallocated expenses were $5.5B.

Annual revenue trend
$54.2BFY2023
$53.1BFY2024
$52.9BFY2025
Intel’s revenue base was broadly stable from FY2023 to FY2025, but the income statement changed substantially because of gross margin, restructuring, and foundry economics.

Cash, debt, capex, and reinvestment capacity

At March 28, 2026, Intel had $17.2B of cash and equivalents, $15.5B of short-term investments, $32.8B of cash plus short-term investments, and $45.0B of total debt. Operating cash flow in Q1 2026 was $1.1B, while additions to property, plant, and equipment were $3.6B in investing cash flows. A simple free-cash-flow lens therefore shows negative cash conversion before considering financing arrangements, government incentives, and partner structures.

Operating cash flow
$1.1B
Q1 2026 cash from operations; positive but not enough to cover cash capex.
Cash capex
$(3.6B)
Q1 2026 additions to property, plant, and equipment in investing cash flows.
Simple FCF
$(2.5B)
Operating cash flow less cash capex; useful for DCF stress testing.
Balance-sheet metric Mar. 28, 2026 Dec. 27, 2025 Research implication
Cash and equivalents $17.247B $14.265B Liquidity rose during Q1 before the April 2026 Ireland SCIP repurchase.
Short-term investments $15.542B $23.151B Investments declined as liquidity was repositioned.
Cash plus short-term investments $32.789B $37.416B Still substantial, but capital needs remain large.
Total debt $45.031B $46.585B Leverage matters because the foundry strategy is capital intensive.

Which turning points still shape Intel today?

Intel’s history is not just a list of old chips; it explains the company’s current strategic tension. The x86 franchise created decades of software compatibility and OEM relationships, but manufacturing delays, GPU-led AI demand, and foundry competition changed the rules. Intel’s official history timeline highlights the foundational moments, while recent filings show the reset now underway.

The shift from microprocessor leader to foundry turnaround

  1. 1971
    Intel introduced the 4004 microprocessor, establishing the technical direction that made the company central to computing.
  2. 1978
    The 8086 launched the x86 line; software compatibility later became one of Intel’s deepest ecosystem advantages.
  3. 1981
    IBM’s PC design win helped x86 become a standard in business computing, creating decades of OEM and enterprise pull.
  4. 1991-1993
    Intel Inside and Pentium turned a component supplier into a consumer-recognized technology brand.
  5. 2017
    The Mobileye acquisition extended Intel into assisted-driving and autonomous-vehicle technology, later reported in All Other.
  6. 2025
    Lip-Bu Tan became CEO, Altera was deconsolidated, and Intel raised capital through SoftBank, the U.S. government, and NVIDIA transactions.
  7. Late 2025
    Intel ramped Intel 18A into high-volume manufacturing, a core milestone for the foundry turnaround and AI PC roadmap.
Intel’s historical moat came from x86 scale; its current strategic test is whether that ecosystem can be paired with a financially sustainable foundry model.

What gives Intel a competitive advantage, and where is the moat under pressure?

Intel’s advantages are real but contested. The company still benefits from x86 software compatibility, OEM relationships, a large installed base, engineering depth, advanced packaging, and a strategically valued manufacturing footprint. But those advantages no longer translate automatically into higher margins. AMD pressures x86 CPUs, NVIDIA dominates many AI accelerator budgets, hyperscalers design custom silicon, Arm-based alternatives are credible in clients and servers, and TSMC and Samsung set the external-foundry benchmark.

How strong are the resources?

x86 ecosystem depthStrong
Client scaleStrong
AI accelerator positionDeveloping
Foundry profitabilityWeak today
Liquidity bufferAdequate

Manufacturing depth and execution constraints

Manufacturing is both Intel’s differentiator and its constraint. The company says nearly all Intel Foundry business presently supports internal manufacturing for Intel Products, while external foundry services are a future growth objective. That means Foundry must serve two purposes at once: supply Intel’s own roadmap and convince external customers that Intel can be a reliable manufacturing partner. The 2026 Computex announcement added useful evidence of product traction: Intel said Xeon 6+ is built on Intel 18A, Series 3 powers more than 325 PC designs, and more than 130 customers had selected Series 3 for edge AI and robotics designs, according to the Computex 2026 press release.

Who are Intel’s main competitors?

Intel competes across several different markets, so a single rival list is misleading. In client CPUs, AMD is the most direct x86 competitor, while Apple, Qualcomm, and MediaTek pressure parts of the Arm-based client market. In data centers, AMD competes in CPUs, NVIDIA shapes AI accelerator demand, hyperscalers such as Amazon, Google, Meta, and Microsoft increasingly design custom silicon, and Arm or RISC-V entrants target specific workloads. In foundry, Intel’s challenge is not just technology; it is customer trust, design enablement, ecosystem breadth, and cost competitiveness against established foundry models.

Where does the competitive pressure show up financially?

Market Key rivals Pressure point Financial line to watch
Client PCs AMD, Apple, Qualcomm, MediaTek Performance per watt, AI PC features, OEM design wins, pricing CCG revenue, CCG operating margin, client ASP and volume commentary
Data center CPUs and AI AMD, NVIDIA, hyperscaler custom silicon, Arm and RISC-V entrants GPU-led AI capex can crowd out CPU spending; custom silicon can reduce dependence on merchant CPUs. DCAI revenue growth, server ASP, DCAI operating income
Foundry TSMC, Samsung, internal customer alternatives Process reliability, packaging breadth, EDA/IP ecosystem, external customer commitments Foundry external revenue, operating loss, capex, depreciation, utilization
High product profit / low manufacturing burden
Pure fabless peers can scale design economics without owning the same fixed fab network.
High product profit / high manufacturing burden
Intel sits here today: strong CCG and DCAI operating income, offset by Foundry losses and heavy reinvestment.
Low product profit / low manufacturing burden
Asset-light challengers with weak product franchises may avoid capex but lack Intel’s ecosystem leverage.
Low product profit / high manufacturing burden
This is the risk quadrant Intel is trying to avoid through product focus, capital discipline, and foundry customers.

Who owns Intel stock, and why does governance matter now?

Intel is not a founder-controlled company with dual-class voting power. Its governance story is dispersed institutional ownership plus a new, unusual government equity position tied to U.S. semiconductor policy. The 2026 proxy statement shows the U.S. government at 433.3M shares, or 8.4% outstanding, assuming full release of certain escrowed shares; Vanguard at 404.5M shares, or 8.1%; and BlackRock at 341.1M shares, or 6.8%.

Institutional and government ownership

Major beneficial-owner stakes disclosed in the 2026 proxy
U.S. government8.4%
Vanguard8.1%
BlackRock6.8%
Bars are scaled to the largest disclosed stake in this group; percentages are ownership of outstanding common stock as disclosed in the 2026 proxy.
Holder or group Shares / stake Source period Why it matters
U.S. government 433.3M shares / 8.4% March 20, 2026 proxy basis Makes semiconductor policy and governance more intertwined; escrowed shares and warrants add dilution complexity.
The Vanguard Group 404.5M shares / 8.1% Dec. 31, 2025 13G/A basis Passive ownership increases focus on governance, compensation, and long-run execution rather than control.
BlackRock 341.1M shares / 6.8% Proxy disclosure basis Another large institutional owner; voting influence matters in board oversight and pay votes.
Directors and executive officers 2.75M Intel shares as a group; each not more than 1% March 20, 2026 proxy basis Management incentives matter, but control is not insider-dominated.

Board and management reset

Governance matters because Intel’s turnaround is not only operational; it is capital-allocation heavy. The proxy says Lip-Bu Tan became CEO effective March 18, 2025, and the board nominated 11 directors for election at the 2026 annual meeting. The same proxy highlights Altera’s 51% divestiture, a Mobileye stake sale, a 2025 restructuring plan, manufacturing expansion rationalization, SoftBank and NVIDIA private placements, and U.S. government agreements. Those are not routine governance details; they are evidence that Intel’s board and management are actively reshaping the business portfolio and balance sheet.

What opportunities and risks should researchers watch?

The upside case is not simply “AI growth.” Intel must translate AI-era demand into CPU relevance, custom silicon, foundry utilization, advanced packaging revenue, and better product margins. The risk case is also not simply “competition.” The filings point to supply constraints, customer concentration, geopolitical exposure, product vulnerabilities, government-agreement complexity, capital intensity, and execution risk in 18A and future nodes.

Opportunities that could change the story

18A product ramp
Watch Series 3 PC designs, Xeon 6+ timing, yields, and whether customer demand converts into margin rather than only revenue.
External foundry wins
The key proof point is external customer revenue and committed volume, not internal transfer activity.
DCAI growth quality
Q1 2026 DCAI revenue rose 22%; researchers should separate ASP, volume, hyperscale mix, and AI infrastructure relevance.
Cash-flow conversion
A DCF model needs evidence that capex intensity falls or product cash flow rises enough to fund the foundry plan.
Capital discipline
No FY2025 share repurchases and no FY2025 dividends show that cash is being preserved for strategic reinvestment.
Government and partner funding
Equity, incentives, and partner structures can reduce funding strain but introduce dilution, restrictions, and governance complexity.

Risks from filings and operating reality

Intel’s 2025 filing says the three largest customers represented 43% of FY2025 net revenue, sales outside the United States represented 70%, and China billing represented 24%. It also warns that product demand can be affected by customer inventory, pricing pressure, export restrictions, supply constraints, and shifts in data-center spending toward GPU systems. Product defects and security vulnerabilities are also material: Intel specifically discusses 13th and 14th Gen desktop processor instability issues and processor security vulnerability categories such as side-channel vulnerabilities.

Risk Official signal Financial impact path Metric to monitor
Foundry execution FY2025 Foundry operating loss of $10.3B Lower utilization or delayed external wins can pressure gross margin and free cash flow. Foundry loss, external revenue, capex, depreciation
Customer concentration Top three customers were 43% of FY2025 revenue Customer inventory corrections or pricing negotiations can move revenue quickly. Customer concentration, CCG and DCAI revenue trends
Geopolitics and trade 70% of FY2025 revenue outside the U.S.; China billing 24% Tariffs, export controls, and regional tensions can affect demand and supply chain access. Regional revenue, export-control disclosures
Product quality and security Filing discusses product instability and side-channel vulnerability risk Warranty costs, reputational damage, performance impacts from mitigations, and delayed purchases. Warranty language, product launch cadence, customer commentary

Why does Intel matter for valuation and DCF analysis?

Intel matters for valuation because its future cash flows are highly sensitive to a few operating assumptions. A simple revenue multiple misses the central issue: two profitable product segments are funding a loss-making foundry transformation while the company carries high debt and capital requirements. In a DCF model, the debate is not whether Intel has strategic assets; it is what those assets cost to maintain, when they can produce acceptable returns, and how much dilution or leverage is required before the payoff arrives.

Which drivers belong in a DCF model?

DCF driver Intel-specific question Base evidence Modeling implication
Revenue growth Can CCG stay resilient while DCAI grows in AI-era infrastructure? Q1 2026 revenue up 7%; DCAI up 22% Separate product growth from foundry transfer activity.
Gross margin Can utilization, mix, and yields restore margin? Q1 2026 GAAP gross margin 39.4%; FY2025 gross margin 34.8% Gross margin is a high-sensitivity assumption.
Operating expenses How much restructuring is one-time versus recurring transformation cost? Q1 2026 restructuring and other charges $4.1B Use normalized and GAAP scenarios separately.
Reinvestment How much capex is required before Foundry scales? Q1 2026 cash capex $3.6B; total debt $45.0B Terminal value depends on sustainable capex intensity.
Capital allocation Will cash go to fabs, debt, acquisitions, dividends, or buybacks? No FY2025 repurchases; no FY2025 dividends; $7.2B remaining buyback authorization Equity value depends on funding choices and dilution.

What is the key takeaway from Intel analysis?

Intel is best understood as a turnaround around a still-material product franchise. CCG and DCAI provide the current profit pool; Foundry and 18A define the strategic option; cash, debt, capex, and government or partner financing define the constraint. The company’s opportunity is to use x86 scale, AI PC demand, inference infrastructure, custom silicon, and geographically important manufacturing to regain relevance. The risk is that Foundry losses, competitive pressure, supply constraints, or capital intensity consume too much of the product cash flow before external customers validate the model.

Final synthesis
For students, Intel is a case study in platform economics, vertical integration, and strategic renewal. For researchers, the most important evidence is not a slogan about AI but the sequence of segment revenue, Foundry operating loss, 18A customer traction, cash-flow conversion, and ownership changes. For investors building a DCF model, the key question is whether Intel can convert strategic manufacturing value into sustainable free cash flow without excessive dilution, leverage, or margin erosion.

DCF model

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support



Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.